Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Neoplasm | 6 | 2020 | 2002 | 0.610 |
Why?
|
| Cancer Vaccines | 3 | 2020 | 1044 | 0.490 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 2570 | 0.470 |
Why?
|
| Counseling | 1 | 2014 | 1551 | 0.250 |
Why?
|
| Melanoma | 1 | 2024 | 5719 | 0.240 |
Why?
|
| Papillomavirus Infections | 2 | 2014 | 1640 | 0.240 |
Why?
|
| Immunotherapy | 3 | 2020 | 4752 | 0.190 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2024 | 825 | 0.170 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2020 | 175 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 2921 | 0.160 |
Why?
|
| Dendritic Cells | 3 | 2020 | 2747 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2014 | 4044 | 0.150 |
Why?
|
| Calreticulin | 1 | 2019 | 111 | 0.150 |
Why?
|
| Mutation | 4 | 2024 | 30198 | 0.120 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 306 | 0.100 |
Why?
|
| Myeloproliferative Disorders | 1 | 2019 | 616 | 0.100 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2020 | 4642 | 0.100 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 10261 | 0.100 |
Why?
|
| Papillomaviridae | 2 | 2014 | 1141 | 0.090 |
Why?
|
| Peptides | 2 | 2019 | 4331 | 0.090 |
Why?
|
| Neoplasms | 2 | 2015 | 22340 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2020 | 1964 | 0.080 |
Why?
|
| Animals | 5 | 2024 | 168764 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3685 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 5197 | 0.050 |
Why?
|
| Mice | 3 | 2024 | 81819 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2020 | 579 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 393 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7425 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2020 | 1162 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 13451 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2020 | 1250 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2020 | 1885 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2020 | 3160 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2014 | 691 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 6832 | 0.020 |
Why?
|
| Humans | 7 | 2020 | 765968 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 3081 | 0.020 |
Why?
|
| Vaccination | 1 | 2020 | 3426 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1490 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4405 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 1995 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 1461 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12795 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5337 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 17075 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 22332 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22223 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9373 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5389 | 0.010 |
Why?
|
| Female | 3 | 2020 | 396112 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12807 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 16047 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59489 | 0.010 |
Why?
|
| Male | 2 | 2020 | 363698 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 171117 | 0.000 |
Why?
|
| Middle Aged | 1 | 2019 | 223009 | 0.000 |
Why?
|
| Adult | 1 | 2019 | 223044 | 0.000 |
Why?
|
Concepts
(58)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_